Search results
Results From The WOW.Com Content Network
CBD commonly refers to: Cannabidiol, a drug component of cannabis; Central business district, of a city; CBD may also refer to: Biology. Ecology.
[23] [24] It may be supplied as CBD oil containing only CBD as the active ingredient (excluding THC or terpenes), CBD-dominant hemp extract oil, capsules, dried cannabis, or prescription liquid solution. [4] [20] CBD does not have the same psychoactivity as THC, [25] [26] and can modulate the psychoactive effects of THC on the body if both are ...
[3] [4] Cannabidiol (CBD) is another major constituent of some cannabis plants. [5] Conversion of CBD to THC can occur when CBD is heated to temperatures between 250–300 °C (480 to 570°F), potentially leading to its partial transformation into THC. [6] At least 113 distinct cannabinoids have been isolated from cannabis. [7]
Cannabidiol diacetate (CBD-di-O-Acetate, CBD-DO) is a semi-synthetic derivative of cannabidiol derived by acetylation of the OH groups, [1] which presumably acts as a prodrug for CBD. It has been found as a component of grey-market cannabis products such as e-cigarette liquids and edible gummy lollies.
This observation may be due to difference in the species of insect and chemical secretions, thus providing a new hypothesis that CBD levels vary in response to certain species or even have no effect. Phytocannabinoid and terpene content in the leaves and flowers of C. sativa rises when under attack by Tetranychus urticae, a common pest for the ...
H4CBD (hydrogenated CBD, tetrahydrocannabidiol) is a cannabinoid that was first synthesized by Alexander R. Todd in 1940 derived from the catalytic hydrogenation of cannabidiol. [ 1 ] H2-CBD and 8,9-dihydrocannabidiol have also been referred to as "hydrogenated CBD", which may cause confusion.
Cannabidiorcol (CBDO, CBD-C1, O-1821) is a phytocannabinoid found naturally in Cannabis in trace concentrations. It is related to cannabidiol , with the pentyl side chain shortened to a methyl group.
A bill allowing cannabis to be legally available on prescription in pharmacies as a medicine was passed by the Czech Chamber of Deputies on 7 December 2012, [10] with 126 votes for legalisation and 7 against (27 abstained and 46 were absent from the vote). [11]